Israeli firm DreaMed Diabetes' diabetes-management software Advisor Pro has been approved for marketing by the FDA. The software is designed to help health care providers manage type 1 diabetes patients who use continuous glucose monitoring and insulin pumps and provides insulin delivery recommendations.
FDA approves DreaMed's diabetes-management software
Sign up for DiabetesPro SmartBrief
News for diabetes health professionals
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.